medigraphic.com
ISSN 2594-1518 (Digital)
ISSN 1405-0099 (Impreso)

2005, Número 1

Siguiente >>

Cir Gen 2005; 27 (1)


Tiroidectomía total o hemitiroidectomía para el tratamiento del cáncer bien diferenciado de tiroides

Hurtado-López LM, Zaldívar-Ramírez FR

Idioma: Español
Referencias bibliográficas: 63
Paginas: 9-13
Archivo PDF: 55.37 Kb.


FRAGMENTO

Siempre que un enfermo presente cáncer diferenciado de tiroides, el cirujano deberá decidir cuál es el mejor tratamiento a seguir; así, encontrará una gran cantidad de información disponible en artículos y libros en la literatura mundial con posiciones completamente polarizadas a este respecto, abarcando un extenso abanico de posibilidades terapéuticas; desde el tratamiento más conservador hasta la cirugía radical. Además, estos tratamientos pueden estar acompañados de adyuvancia con dosis ablativa de yodo radiactivo y/o hormonoterapia de sustitución o supresión. Para complicar aún más esta decisión terapéutica existen un sinfín de factores pronósticos que modificarán el resultado de la decisión tomada.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cady B. Hayes Martin Lecture. Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997; 174: 462-8.

  2. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995; 118: 1131-6; discussion 1136-8.

  3. Benninger MS, Guillen JB, Altman JS. Changing etiology of vocal fold immobility. Laryngoscope 1998; 108: 1346-50.

  4. Havas T, Lowinger D, Priestley J. Unilateral vocal fold paralysis: causes, options and outcomes. Aust N Z J Surg 1999; 69: 509-13.

  5. Fewins J, Simpson CB, Miller FR. Complications of thyroid and parathyroid surgery. Otolaryngol Clin North Am 2003; 36: 189-206.

  6. Udelsman R, Lakatos E, Ladenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg 1996; 20: 88-93.

  7. Koyuncu A, Dokmetas HS, Turan M, Aydin C, Karadayi K, Budak E, et al. Comparison of different thyroidectomy techniques for benign thyroid disease. Endocr J 2003; 50: 723-7.

  8. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004; 28: 271-6.

  9. Filho JG, Kowalski LP. Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. Am J Otolaryngol 2004; 25: 225-30.

  10. Kupferman ME, Mandel SJ, DiDonato L, Wolf P, Weber RS. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope 2002; 112(7 Pt 1): 1209-12.

  11. Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 2002; 128: 389-92.

  12. Gough IR, Wilkinson D. Total thyroidectomy for management of thyroid disease. World J Surg 2000; 24: 962-5.

  13. Clark OH. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196: 361-70.

  14. Rodríguez CSA, Labastida AS, Olano LOR, Muñoz CML. Morbilidad debida a tiroidectomía por cáncer de tiroides. Estudio comparativo de pacientes tratados en hospitales generales y en el hospital de Oncología del Centro Médico Nacional del Instituto Mexicano del Seguro Social. Cir Gen 1996; 18: 92-7.

  15. Hurtado LLM, Pulido CA, Basurto KE. Puntos clave para una adecuada y segura identificación del nervio laríngeo recurrente durante la tiroidectomía. Aplicación en 100 tiroidectomías. Cir Gen 1998; 20: 95-8.

  16. Hurtado LLM, Pulido CA, Zaldívar RR, Basurto KE. A propósito de la localización del nervio laríngeo recurrente y las glándulas paratiroides inferior en la cirugía de tiroides. Cir Gen 2000; 22: 283-6.

  17. Pulido CA, Hurtado LLM, Basurto KE, Cárdenas OA, Muñoz SO, Zaldívar RR, et al. Sistematización de la técnica de tiroidectomía y su impacto en la morbilidad. Cir Gen 2004; 26: 286-9.

  18. Hurtado LLM, Zaldívar RFR, Basurto KE, Pulido CA, Muñoz SO, Cárdenas OA. La morbilidad no limita la extensión quirúrgica del cáncer diferenciado de tiroides. Cir Gen 2003; 25(Supl 1): s9-s10.

  19. Pasieka JL, Rotstein LE. Consensus conference on well-differentiated thyroid cancer: a summary. Can J Surg 1993; 36: 298-301.

  20. Cernea CR, Ferraz AR, Nishio S, Dutra A Jr, Hojaij FC, dos Santos LR. Surgical anatomy of the external branch of the superior laryngeal nerve. Head Neck 1992; 14: 380-3.

  21. Hurtado-López LM, Zaldívar-Ramírez FR. Risk of injury to the external branch of the superior laryngeal nerve in thyroidectomy. Laryngoscope 2002; 112: 626-9.

  22. Cernea CR, Ferraz AR, Furlani J, Monteiro S, Nishio S, Hojaij FC, et al. Identification of the external branch of the superior laryngeal nerve during thyroidectomy. Am J Surg 1992; 164: 634-9.

  23. Hurtado-López LM, Pacheco-Álvarez MI, Montes-Castillo MDL, Zaldívar-Ramírez FR. Importance of the intraoperative identification of the external branch of the superior laryngeal nerve during thyroidectomy electromyographic evaluation. Thyroid (in press)

  24. Madrid FJR, Lozano LI. Enfermedad quirúrgica no traumática del cuello ¿estoy preparado para enfrentarla? Cir Gen 2004; 26: 156-8.

  25. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998; 228: 320-30.

  26. Bacourt F, Asselain B, Savoie JC, D’Hubert E, Massin JP, Doucet G, et al. Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age. Br J Surg 1986; 73: 274-7.

  27. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986; 61: 978-96.

  28. Avenia N, Ragusa M, Monacelli M, Calzolari F, Daddi N, Di Carlo L, et al. Locally advanced thyroid cancer: therapeutic options. Chir Ital 2004; 56: 501-8.

  29. Marchesi M, Biffoni M, Biancari F, Berni A, Campana FP. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl 2003; (588): 46-50.

  30. Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999; 84: 4043-9.

  31. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 1977; 56: 171-96.

  32. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, et al. A prognostic index for thyroid carcinoma. A study of the EORTC. Thyroid Cancer Cooperative Group. Eur J Cancer 1979; 15: 1033-41.

  33. Simpson WJ, McKinney SE. Canadian survey of thyroid cancer. Can Med Assoc J 1985; 132: 925-31.

  34. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 1987; 83: 479-88.

  35. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102: 1088-95.

  36. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104: 947-53.

  37. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050-7; discussion 1057-8.

  38. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 414-24.

  39. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995; 118: 1131-6; discussion 1136-8.

  40. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998; 83: 1012-21.

  41. Mazzaferri EL. NCCN thyroid carcinoma practice guidelines. Oncology 1999; 13(11A, NCCN proceedings): 391-442.

  42. Rodriguez-Cuevas S, Labastida Almendaro S, Reyes Cardoso JM, Rodriguez Maya E. Papillary thyroid cancer in México: review of 409 cases. Head Neck 1993; 15: 537-45.

  43. Herrera MF, Lopez-Graniel CM, Saldaña J, Gamboa-Dominguez A, Richaud-Patin Y, Vargas-Vorackova F, et al. Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors. World J Surg 1996; 20: 94-9; discussion 99-100.

  44. Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 2002; 9: 227-47.

  45. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994; 18: 559-67; discussion 567-8.

  46. Beasley NJ, Lee J, Eski S, Walfish P, Witterick I, Freeman JL. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 825-8.

  47. Clark OH. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196: 361-70.

  48. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29: 1790-4.

  49. Dackiw AP, Zeiger M. Extent of surgery for differentiated thyroid cancer. Surg Clin North Am 2004; 84: 817-32.

  50. Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984; 53: 982-92.

  51. Mishra A, Mishra SK, Agarwal A, Das BK, Agarwal G, Gambhir S. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. World J Surg 2002; 26: 153-7.

  52. Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994; 18: 600-4.

  53. Zohar Y, Strauss M. Occult distant metastases of well-differentiated thyroid carcinoma. Head Neck 1994; 16: 438-42.

  54. Mazzaferri EL, Kloos RT. Clinical review: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86: 1447-63.

  55. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124: 958-64; discussion 964-6.

  56. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994; 18: 123-30.

  57. Cushing SL, Palme CE, Audet N, Eski S, Walfish PG, Freeman JL. Prognostic factors in well-differentiated thyroid carcinoma. Laryngoscope 2004; 114: 2110-5.

  58. Orsenigo E, Beretta E, Fiacco E, Scaltrini F, Veronesi P, Invernizzi L, et al. Management of papillary microcarcinoma of the thyroid gland. Eur J Surg Oncol 2004; 30: 1104-6.

  59. Kim S, Wei JP, Braveman JM, Brams DM. Predicting outcome and directing therapy for papillary thyroid carcinoma. Arch Surg 2004; 139: 390-4; discussion 393-4.

  60. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004; 114: 393-402.

  61. Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 2004; 22: 3531-9.

  62. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004; 89: 3713-20.

  63. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: current status and future prospects. Thyroid 2004; 14: 424-34.




2020     |     www.medigraphic.com